www.editasmedicine.com Open in urlscan Pro
35.185.31.195  Public Scan

Form analysis
0 forms found in the DOM

Text Content

Skip to Main Content
 * Newsroom
 * Get in Touch
 * LinkedIn
 *   

Editas Medicine Linkedin
 * Research and Pipeline
 * CRISPR Gene Editing
 * For Patients
 * Who We Are
 * Join Our Team
 * Investors

 * Newsroom
 * Get in Touch
 * LinkedIn
 *   




WHAT IF WE COULD REPAIR BROKEN GENES?

That is the question we ask ourselves at Editas Medicine.

At Editas Medicine, we are pioneering the possible. Our mission and commitment
is to harness the power and potential of CRISPR gene editing to develop a robust
pipeline of medicines for people living with serious diseases around the world.
Our goal is to discover, develop, manufacture, and commercialize transformative,
durable genomic medicines for many diseases.

Animating slideshow of images Young woman holding her dog. Young man in hospital
bed listening to a doctor. Geneticist in a lab working on genomic editing.
Editas Medicine’s Newsroom
Sep
25
Editas Medicine Reports Inducement Grants to New Chief Commercial and Strategy
Officer
Sep
25
Editas Medicine Strengthens Executive Leadership Team with Appointment of Caren
Deardorf as Chief Commercial and Strategy Officer
Aug
30
Editas Medicine Announces Upcoming Investor Events
 * 1
 * 2
 * 3

Editas Medicine’s Newsroom
 * Sep
   25
   Editas Medicine Reports Inducement Grants to New Chief Commercial and
   Strategy Officer
 * Sep
   25
   Editas Medicine Strengthens Executive Leadership Team with Appointment of
   Caren Deardorf as Chief Commercial and Strategy Officer
 * Aug
   30
   Editas Medicine Announces Upcoming Investor Events

What We’re Working On

Our pipeline includes a broad range of experimental medicines. See what we’re
working on.

Our pipeline includes a broad range of experimental medicines. See what we’re
working on.

The Science Behind It All

CRISPR (pronounced “crisper”) is an acronym for “Clustered, Regularly
Interspaced, Short Palindromic Repeats,” and refers to a recently developed gene
editing technology that can revise, remove, and replace DNA in a highly targeted
manner. At Editas Medicine, we are using this technology to develop
transformative and durable medicines for people living with serious diseases.

CRISPR (pronounced “crisper”) is an acronym for “Clustered, Regularly
Interspaced, Short Palindromic Repeats,” and refers to a recently developed gene
editing technology that can revise, remove, and replace DNA in a highly targeted
manner. At Editas Medicine, we are using this technology to develop
transformative and durable medicines for people living with serious diseases.

The People We Serve

We are motivated to deliver transformative medicines to the greatest number of
patients around the world. Learn more about our commitment.

We are motivated to deliver transformative medicines to the greatest number of
patients around the world. Learn more about our commitment.

About Editas Medicine

Learn more about Editas Medicine, the work we do, and the team that makes
everything possible.

Learn more about Editas Medicine, the work we do, and the team that makes
everything possible.

Life at Editas Medicine

Get to know our Inspiritas culture and see if any of our career openings could
be right for you.

Get to know our Inspiritas culture and see if any of our career openings could
be right for you.

Investors



Get in Touch


+ -
Editas Newsroom
Sep
25
Editas Medicine Reports Inducement Grants to New Chief Commercial and Strategy
Officer
Sep
25
Editas Medicine Strengthens Executive Leadership Team with Appointment of Caren
Deardorf as Chief Commercial and Strategy Officer
Aug
30
Editas Medicine Announces Upcoming Investor Events
 * Research and Pipeline
 * CRISPR Gene Editing
 * For Patients
 * Who We Are
 * Join Our Team
 * Investors

--------------------------------------------------------------------------------

 * Terms of Use
 * Privacy Policy
 * Get in Touch
 * Newsroom

Editas Medicine Linkedin
©Copyright 2023 Editas Medicine